EDIT - Editas Medicine, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$5.00
DETAILS
HIGH:
$6.00
LOW:
$4.00
MEDIAN:
$5.00
CONSENSUS:
$5.00
UPSIDE:
81.16%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 40.5 | 32.3 | 78.1 | 19.7 | 25.5 | 90.7 | 20.5 | 31.9 | 13.7 | 6.1 | 1.6 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 6.1 | 6.3 | 5.1 | 158.0 | 96.9 | 90.7 | 83.2 | 57.0 | 18.8 | 5.1 | 1.6 |
| Gross Profit | 40.5 | 32.3 | 72.1 | 13.4 | 20.5 | (67.3) | (76.4) | (58.7) | (69.4) | (50.9) | (17.2) | (5.1) | (1.6) |
| Operating Expenses | |||||||||||||
| R&D Expenses | 90.0 | 199.2 | 177.7 | 175.0 | 142.5 | 158.0 | 96.9 | 90.7 | 83.2 | 57.0 | 18.8 | 5.1 | 1.6 |
| SG&A Expenses | 49.9 | 72.0 | 69.7 | 70.7 | 76.2 | 67.6 | 64.6 | 55.0 | 50.5 | 46.3 | 18.1 | 7.7 | 3.6 |
| Other Expenses | 0 | 12.2 | (6.1) | (6.3) | (5.1) | (158.0) | (96.9) | 0.3 | 0.6 | (0.1) | (37.4) | (0.9) | 0 |
| Operating Expenses | 139.9 | 283.5 | 241.2 | 239.3 | 213.6 | 67.6 | 64.6 | 145.7 | 133.7 | 103.2 | 36.9 | 12.7 | 3.7 |
| Operating Income | |||||||||||||
| Operating Income | (99.3) | (251.2) | (169.2) | (225.9) | (193.1) | (134.8) | (140.9) | (113.7) | (119.9) | (97.2) | (35.3) | (12.7) | (5.2) |
| Interest Expense | 6.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.0 | 0 | 0.1 | 0.0 | 0 |
| Interest Income | 8.3 | 14.1 | 17.6 | 5.5 | 0.6 | 2.6 | 7.3 | 3.4 | 0 | 0.1 | 0 | 0 | 0 |
| Profitability | |||||||||||||
| EBITDA | (148.6) | (233.1) | (163.1) | (219.6) | (188.1) | (130.9) | (138.1) | (110.5) | (116.7) | (96.1) | (72.3) | (13.5) | (5.2) |
| EBIT | (153.9) | (238.9) | (169.2) | (225.9) | (193.1) | (134.8) | (140.9) | (113.7) | (119.3) | (97.2) | (72.8) | (12.7) | (5.2) |
| Income Before Tax | (160.1) | (237.1) | (153.2) | (220.4) | (192.5) | (116.0) | (133.7) | (110.0) | (120.3) | (97.2) | (72.9) | (13.7) | (5.3) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1.1) | 0 | 0 | 0 | 0 |
| Net Income | (160.1) | (237.1) | (153.2) | (220.4) | (192.5) | (116.0) | (133.7) | (110.0) | (120.3) | (97.2) | (72.9) | (13.7) | (5.3) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -1.80 | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 | -2.47 | -2.33 | -2.98 | -3.02 | -2.04 | -5.34 | -0.18 |
| EPS (Diluted) | -1.80 | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 | -2.47 | -2.33 | -2.98 | -3.02 | -2.04 | -5.34 | -0.18 |
| Shares Outstanding | 88.7 | 82.3 | 76.0 | 68.7 | 67.6 | 58.6 | 50.0 | 47.1 | 40.3 | 32.2 | 35.7 | 2.6 | 30.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 146.6 | 131.5 | 123.7 | 141.5 | 203.5 | 139.7 | 238.2 | 134.8 | 146.6 | 185.3 |
| Short-Term Investments | 0 | 138.4 | 199.5 | 202.8 | 296.3 | 262.4 | 219.0 | 234.2 | 182.5 | 0 |
| Net Receivables | 15.2 | 16.3 | 10.2 | 5.1 | 0.3 | 6.0 | 0.4 | 0.0 | 0.7 | 0.1 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.9 | 1.9 | 1.7 |
| Other Current Assets | 2.1 | 3.1 | 7.5 | 7.3 | 0 | 0 | 6.3 | 0 | 0.5 | 0.1 |
| Total Current Assets | 163.9 | 289.3 | 340.8 | 356.8 | 507.3 | 419.1 | 463.8 | 374.8 | 332.2 | 187.2 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 19.7 | 47.1 | 45.7 | 59.2 | 43.3 | 39.1 | 39.6 | 40.2 | 39.4 | 40.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 2.7 | 0 | 104.0 | 93.1 | 120.1 | 109.7 | 3.7 | 5.4 | 1.6 | 1.6 |
| Other Non-Current Assets | 0.3 | 5.2 | 8.6 | 5.3 | 6.8 | 4.7 | 1.7 | 0 | 0 | 0 |
| Total Non-Current Assets | 22.6 | 52.3 | 158.3 | 157.6 | 170.2 | 153.5 | 45.0 | 45.6 | 41.1 | 42.0 |
| Total Assets | 186.5 | 341.6 | 499.2 | 514.3 | 677.5 | 572.6 | 508.9 | 420.4 | 373.3 | 229.2 |
| Current Liabilities | ||||||||||
| Account Payables | 2.6 | 5.5 | 8.3 | 9.5 | 5.0 | 6.4 | 5.8 | 5.3 | 4.0 | 4.6 |
| Short-Term Debt | 11.0 | 0 | 12.0 | 0 | 0 | 0 | 0 | 0 | 7.5 | 10 |
| Deferred Revenue | 44.5 | 11.2 | 8.2 | 8.2 | 11.3 | 20.9 | 23.5 | 15.7 | 13.2 | 26 |
| Other Current Liabilities | (11.9) | 22.0 | (0.7) | 10.1 | 10.2 | 5.3 | 19.8 | 9.7 | 8.2 | 1.0 |
| Total Current Liabilities | 46.2 | 77.2 | 63.2 | 60.1 | 46.9 | 58.2 | 60.0 | 35.9 | 36.7 | 33.1 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 53.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.4 |
| Other Non-Current Liabilities | 2.8 | 3.1 | 1.8 | 0 | 0 | 27.5 | 0.0 | 0.3 | 0.3 | 0.4 |
| Total Non-Current Liabilities | 113 | 130.1 | 86.8 | 93.5 | 77.0 | 120.8 | 186.5 | 148.3 | 128.5 | 61.5 |
| Total Liabilities | 159.2 | 207.3 | 150.1 | 153.6 | 123.8 | 179.0 | 246.4 | 184.2 | 165.2 | 94.6 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,628.5) | (1,468.4) | (1,231.3) | (1,078.1) | (857.7) | (665.2) | (549.2) | (416.3) | (305.9) | (185.5) |
| Accumulated Other Comprehensive Income | 0 | 0.3 | 0.2 | (3.6) | (0.5) | (0.0) | 0.1 | (0.0) | (0.1) | (229.2) |
| Total Stockholders' Equity | 27.3 | 134.3 | 349.1 | 360.7 | 553.6 | 393.6 | 262.4 | 236.2 | 208.1 | 134.6 |
| Total Liabilities & Equity | 186.5 | 341.6 | 499.2 | 514.3 | 677.5 | 572.6 | 508.9 | 420.4 | 373.3 | 229.2 |
| Debt Metrics | ||||||||||
| Total Debt | 76.7 | 35.0 | 48.5 | 43.9 | 26.4 | 26.1 | 29.1 | 32.4 | 33.4 | 35.1 |
| Net Debt | (69.9) | (96.5) | (75.1) | (97.6) | (177.1) | (113.5) | (209.1) | (102.4) | (113.2) | (150.2) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (160.1) | (237.1) | (153.2) | (220.4) | (192.5) | (116.0) | (133.7) | (110.0) | (120.3) | (97.2) |
| Depreciation & Amortization | 5.3 | 5.8 | 6.1 | 6.3 | 5.1 | 4.0 | 2.8 | 3.3 | 2.7 | 1.2 |
| Stock-Based Compensation | 10 | 21.4 | 19.8 | 29.3 | 43.4 | 23.2 | 27.2 | 26.6 | 23.4 | 16.9 |
| Change in Working Capital | (31.2) | 3.5 | (1.6) | 8.2 | (21.4) | (102.2) | 65.9 | 26.9 | 70.7 | 18.5 |
| Other Non-Cash Items | 10.8 | (3.9) | (3.2) | (0.7) | 1.7 | 27.6 | (2.9) | 11.2 | 14.2 | 10.6 |
| Operating Cash Flow | (165.2) | (210.3) | (132.2) | (177.3) | (163.8) | (179.8) | (40.7) | (45.7) | (9.4) | (49.9) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.6) | (8.8) | (4.7) | (4.1) | (8.0) | (7.2) | (6.2) | (4.8) | (2.1) | (3.5) |
| Acquisitions | 0.3 | 0 | 0 | 0.0 | 46.5 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Purchases of Investments | 0 | (86.2) | (258.5) | (315.2) | (408.9) | (458.4) | (342.2) | (459.4) | (375.3) | 0 |
| Sales/Maturities of Investments | 139.0 | 257.2 | 259.5 | 433.4 | 362.4 | 325.0 | 360.5 | 411 | 193.5 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (46.5) | 0 | 0 | 0.0 | 0.0 | (1.6) |
| Investing Cash Flow | 138.7 | 162.1 | (3.7) | 114.1 | (54.5) | (140.5) | 12.3 | (53.1) | (183.8) | (5.1) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (2.9) | 0 | 0 | 0 | 0 | 0 | 0 | (0.9) | (0.8) | (0.6) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 1.0 | 0 | 32.6 | 20.4 | 15.5 | 11.0 | 155.3 | 0.2 |
| Financing Cash Flow | 40.5 | 56.0 | 118.0 | 1.3 | 282.1 | 224.1 | 131.8 | 86.9 | 154.5 | 97.2 |
| Cash Position | ||||||||||
| Net Change in Cash | 13.9 | 7.9 | (17.9) | (62.0) | 63.8 | (96.2) | 103.4 | (11.9) | (38.7) | 42.1 |
| Cash at Beginning | 135.4 | 127.5 | 145.4 | 207.4 | 143.6 | 239.8 | 136.4 | 148.2 | 186.9 | 143.2 |
| Cash at End | 149.3 | 135.4 | 127.5 | 145.4 | 207.4 | 143.6 | 239.8 | 136.4 | 148.2 | 185.3 |
| Free Cash Flow | (165.8) | (219.1) | (136.9) | (181.5) | (171.8) | (187.0) | (46.8) | (50.5) | (11.5) | (53.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 40.5 | 32.3 | 78.1 | 19.7 | 25.5 | 90.7 | 20.5 | 31.9 | 13.7 | 6.1 | 1.6 | 0 | 0 |
| Gross Profit | 40.5 | 32.3 | 72.1 | 13.4 | 20.5 | (67.3) | (76.4) | (58.7) | (69.4) | (50.9) | (17.2) | (5.1) | (1.6) |
| Operating Income | (99.3) | (251.2) | (169.2) | (225.9) | (193.1) | (134.8) | (140.9) | (113.7) | (119.9) | (97.2) | (35.3) | (12.7) | (5.2) |
| Net Income | (160.1) | (237.1) | (153.2) | (220.4) | (192.5) | (116.0) | (133.7) | (110.0) | (120.3) | (97.2) | (72.9) | (13.7) | (5.3) |
| EPS (Diluted) | -1.80 | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 | -2.47 | -2.33 | -2.98 | -3.02 | -2.04 | -5.34 | -0.18 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 146.6 | 131.5 | 123.7 | 141.5 | 203.5 | 139.7 | 238.2 | 134.8 | 146.6 | 185.3 | |||
| Total Assets | 186.5 | 341.6 | 499.2 | 514.3 | 677.5 | 572.6 | 508.9 | 420.4 | 373.3 | 229.2 | |||
| Total Debt | 76.7 | 35.0 | 48.5 | 43.9 | 26.4 | 26.1 | 29.1 | 32.4 | 33.4 | 35.1 | |||
| Stockholders' Equity | 27.3 | 134.3 | 349.1 | 360.7 | 553.6 | 393.6 | 262.4 | 236.2 | 208.1 | 134.6 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (165.2) | (210.3) | (132.2) | (177.3) | (163.8) | (179.8) | (40.7) | (45.7) | (9.4) | (49.9) | |||
| Capital Expenditure | (0.6) | (8.8) | (4.7) | (4.1) | (8.0) | (7.2) | (6.2) | (4.8) | (2.1) | (3.5) | |||
| Free Cash Flow | (165.8) | (219.1) | (136.9) | (181.5) | (171.8) | (187.0) | (46.8) | (50.5) | (11.5) | (53.4) | |||